MNPR 8-K 2026-11-12

Monopar Therapeutics (MNPR) 8-K dated 2026-11-12 — accession 0001437749-26-036385.

Monopar Therapeutics (MNPR) is a biotechnology company listed on US.

Monopar Therapeutics filed a 8-K on 2026-11-12. Accession 0001437749-26-036385.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MNPR revenue for 2025-12-31 was $0. Net income was -$13.7M. MNPR currently screens at market cap $431.4M.

Not investment advice. The MNPR SEC hub lists recent forms. The stock page is the research view.